Biomarkers of Pain and Stress Perception and Dry Needling Technique Application
Changes in Biomarkers of Pain and Stress Perception After the Application of a Dry Needling Technique in Patients With Low Back Pain
The use of the dry needling technique has become widespread in recent years for the treatment of musculoskeletal pain. Although dry needling has been shown to be effective in the treatment of shoulder pain, elbow pain, headache, etc., we do not yet have a clear understanding of the mechanisms of action that justify its beneficial effects.
In this study, we propose to analyse the biochemical markers of pain generated by the application of a dry needling technique on the lumbar musculature in patients with mechanical lumbar pain of non-specific origin.
The aim of this study will be to evaluate the effects of dry needling technique on the plasmatic concentration of biochemical markers.Furthermore, the test subjects will be randomly distributed into two groups.
An experimental group where the subjects will receive a real dry needling technique.
Another group will be treated with a sham technique.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Patricia Martínez-Merinero, PhD
- Phone Number: +34 683378391
- Email: clinica.fisio@fgua.es
Study Locations
-
-
Madrid
-
Alcalá De Henares, Madrid, Spain, 28805
- Centro Investigación Fisioterapia y Dolor
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Mechanical lumbar pain of more than three months of evolution.
Exclusion Criteria:
- Medical diagnosis of lumbar disc herniation or protrusion.
- Low back and leg pain.
- Pregnancy.
- Fibromyalgia.
- Fear of needles.
- Medication with anticoagulants
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Real dry needling
Subjects included in this group will receive a session with dry needling in the quadratus lumborum muscle.
|
Subjects will be treated with dry needling to the quadratus lumborum muscle. To do this, the subject will be lying laterally on the contralateral side and with the hip in an adducted position. Ten incisions will be made in the muscle. The head will rest comfortably on a pillow |
|
Sham Comparator: Sham dry needling
Subjects included in this group will receive a session with sham dry needling in the quadratus lumborum muscle.
|
Subjects will be treated with dry needling to the quadratus lumborum muscle. To do this, the subject will be lying laterally on the contralateral side and with the hip in an adducted position. The placebo needle will move 10 times imitating the real procedure. The head will rest comfortably on a pillow |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Extracting Blood Samples and Obtaining Serum/Plasma
Time Frame: Change from Baseline concentration at 2 hours
|
Serum samples will be extracted by venipuncture at the cubital fossa, according to a standardized protocol.
Blood will be collected in a tube for serum (Vacutainer SST II Advance, model 367953) and a tube for plasma (Vacutainer PST II Advance, model 367374) separation.
Substances related to antinociception will be determined later: Dopamine, adrenaline, norepinephrine, cortisol.
|
Change from Baseline concentration at 2 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Tomas Gallego-Izquierdo, PhD, Centro de Investigación Fisioterapia y Dolor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 0018-N-23
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.